 | Issue navigator |
| |
Retrovirology publishes selected research, proceedings and collections of thematic reviews as supplements. All articles published in supplements are subject to peer review and are free to access online. The journal also publishes supplements containing meeting abstracts.
Contents of Volume 6 Suppl 3
AIDS Vaccine 2009
Meeting abstracts  A single PDF containing all abstracts in this Supplement is available here.
from AIDS Vaccine 2009
Paris, France. 19 22 October 2009
Edited by Anna Laura Ross
|
Oral presentation
S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers
SA Freel, PK Chattopadhyay, L Lamoreaux, D Zarkowsky, RG Overman, C Ochsenbauer-Jambor, JC Kappes, CK Cunningham, TN Denny, KJ Weinhold, G Ferrari, RA Koup, BS Graham, BF Haynes, M Roederer, GD Tomaras
Retrovirology 2009, 6(Suppl 3):O1 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania
RN Koehler, AM Walsh, E Saathoff, JR Currier, CT Bautista, N Moqueet, S Ratto-Kim, L Maboko, M Hoelscher, ML Robb, NL Michael, FE McCutchan, JH Kim, GH Kijak
Retrovirology 2009, 6(Suppl 3):O2 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
S011-06 OA. HIV specific T cell responses and response patterns associated with viral control independent of classical non-progessor HLA class I alleles
R Zuniga, B Mothe, A Llano, J Ibarrondo, M Daniels, M Farfan, J Suarez, JJ Szinger, W Hildebrand, A Lucchetti, D Heckerman, P Goulder, BD Walker, J Sanchez, BT Korber, C Brander
Retrovirology 2009, 6(Suppl 3):O3 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects
S Munshaw, H Liao, A Dixon, X Chen, A Nagel, K Derosa, R Parks, J Amos, JF Whitesides, DJ Marshalls, Y Yang, F Gao, GD Tomaras, MA Moody, GH Kelsoe, TC Shea, DM Margolis, M Markowitz, P Goepfert, G Shaw, BF Haynes, TB Kepler
Retrovirology 2009, 6(Suppl 3):O4 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
L Song, ZJ Sun, KE Coleman, MB Zwick, JS Gach, J Wang, EL Reinherz, G Wagner, M Kim
Retrovirology 2009, 6(Suppl 3):O5 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
SK Phogat, L Walker, D Wagner, P Chan-Hui, M Simek, P Phung, T Wrin, J Mitcham, P Investigator, S Kaminsky, T Zamb, M Moyle, W Koff, D Burton
Retrovirology 2009, 6(Suppl 3):O6 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA011-01. Early events of human immunodeficiency virus type 1 (HIV-1) ex vivo penetration in the foreskin mimicking HIV-1 sexual transmission
Y Ganor, Z Zhou, A Schmitt, M Vacher-Lavenu, L Gibault, N Thiounn, J Tomasini, J Wolf, M Bomsel
Retrovirology 2009, 6(Suppl 3):O7 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
AM Carias, S McCoombe, M McRaven, M Anderson, R Veazey, TJ Hope
Retrovirology 2009, 6(Suppl 3):O8 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA011-03. Clusterin, a natural ligand of DC-SIGN present in human semen inhibits HIV capture and transmission by dendritic cells
J Sabatte, W Faigle, A Ceballos, W Morelle, C Rodríguez, F Remes Lenicov, M Thépaut, F Fieschi, H Lortat-Jacob, J Michalski, F Arenzana-Seisdedos, J Geffner, S Amigorena
Retrovirology 2009, 6(Suppl 3):O9 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA011-04. Striking elevations in systemic and mucosal cytokine and chemokine levels in acute HIV-1 infection
A Stacey, P Norris, O Dibben, L Qin, M Cohen, C Gay, T Denny, P Borrow
Retrovirology 2009, 6(Suppl 3):O10 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA011-05. TLR-mediated pDC responses to HIV-1 ligands
J Chang, S Kulkarni, A Meier, RJ Lindsay, S Bazner, JD Lifson, RJ Bosch, M Carrington, M Altfeld
Retrovirology 2009, 6(Suppl 3):O11 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission
JR Lingappa, JP Hughes, D Donnel, JM Baeten, JI Mullins, MS Campbell, GE Gray, M Essex, C Farquhar, H Rees, A Wald, L Corey, C Celum
Retrovirology 2009, 6(Suppl 3):O12 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
B Jacobs, K Kibler, S Wong, T Huynh, S Holechek, K Denzler, W Arndt, M Parrington, J Tartaglia, G Pantaleo
Retrovirology 2009, 6(Suppl 3):O13 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
F Tangy, M Février, M Guerbois, C Combredet, V Najburg, C Ruffié, A Morris, O Schwartz, R Legrand
Retrovirology 2009, 6(Suppl 3):O14 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
AK Wheatley, MR Alexander, JG Toe, RJ Center, DF Purcell
Retrovirology 2009, 6(Suppl 3):O15 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
X Shen, M Dennison, F Gao, DC Montefiori, L Verkoczy, B Haynes, M Alam, G Tomaras
Retrovirology 2009, 6(Suppl 3):O16 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein
IC Lorenz, HT Nguyen, SK Phogat, SM Kaminsky, TJ Zamb, CL Parks
Retrovirology 2009, 6(Suppl 3):O17 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
J Cummings, V Arnold, K Yarbrough, C Didier, Y Levy, F Barré-Sinoussi, D Scott-Algara, HIV Vaccine Group
Retrovirology 2009, 6(Suppl 3):O18 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA031-01. HIV-1 infection is characterized by early loss of CD161+ Th17 cells and gradual decline in regulatory T cells
A Prendergast, JG Prado, Y Kang, F Chen, LA Riddell, G Luzzi, P Goulder, P Klenerman
Retrovirology 2009, 6(Suppl 3):O19 (22 October 2009)
[Abstract] [Full text] [PDF]
Oral presentation
OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway
M Nikolova, M Carriere, J Lelievre, M Muhtarova, A Bensussan, Y Lévy
Retrovirology 2009, 6(Suppl 3):O20 (22 October 2009)
[Abstract] [Full text] [PDF]
| |
|   |
